Wednesday, 4 November 2015

International Conference and Exhibition on Dual Diagnosis

About Conference


It’s our pleasure to welcome you to the International Conference and exhibition on Dual Diagnosis, during July 18-19, 2016 in Chicago, USA. The conference will be organized around the theme “Research strategies, advanced technologies and innovations in Dual Diagnosis”.
Dual Diagnosis 2016 will provide an opportunity for all marketing societies working on Drug addiction and co-occurring psychiatric disorders to talk about their work. Dual Diagnosis 2016 will congregate renowned speakers, investigators, Nobel laureates, neurology scientists and Drug addiction and Psychiatry researchers from both academia and health care industry will join together to discuss their views and research. The conference will be operated by world class experts in the field of neurology. International symposiums, B2B meetings, workshops will also be organised to discuss the specific topics in the field of Dual Diagnosis, Drug addiction, mental illness and Neurological disorders.
In USA specialist mental health grew by 61% between 2010 and 2014. USA's mental health system, 29% of state and territory mental health spending was dedicated to caring for people in the community by 2014, the share of total Dual Diagnosis and mental health expenditure had increased to 53%.
Chicago is the third most populous city in the United States. With over 2.7 million residents, it is the most populous city in the state of Illinois and the Midwest. The Chicago metropolitan area, often referred to as Chicago land, is home to nearly 10 million people and is the third-largest in the U.S.A.
The increase in the numbers of heroin-related deaths from 2011 to 2012 in the suburban counties around Chicago was the most important finding for the Chicago area for this reporting period. The increases in heroin-related deaths were observed in the suburban Chicago counties of DuPage, Lake, Will, McHenry, and Kane. Epidemiological indicators suggested that heroin, cocaine, and marijuana/cannabis continued to be the most common illicit substances appearing in drug indicators in Chicago during this reporting period. These were also the drugs that were most frequently identified among drug reports from items seized by law enforcement and analysed in National Forensic Laboratory Information System (NFLIS) forensic laboratories in the first half of 2013; they accounted for 76 percent of all drug reports among drug items seized and analysed.
Statistically, 8.3 million or 55% of USA aged 16–85 will experience drug induced mental health condition like depression, anxiety or drug addiction, according to the 2009 National Institute of Drug Abuse. Dual Diagnosis will help for the treatment of both drug addiction and comorbid mental disorders March 2010 survey suggests almost 64,000 people have a psychotic illness and are in contact with public specialised mental health services.
Why to attend???
Dual Diagnosis 2016 will provide an opportunity for all stakeholders working on Drug addiction and co-occurring psychiatric disorders to talk about their work. Dual Diagnosis- 2016 will congregate renowned speakers, principal investigators, experts, neurologist’s and Drug addiction and Psychiatry researchers from both academia and health care industry will join together to discuss their views and research. The conference will be comprised of sessions by world class experts in the field of neurology. International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Drug addiction, mental health and Neurology.
Target Audience:
The target audience includes Directors, Vice Presidents, Psychiatrist, Neuro-psychiatrist, Psychologist, Brand Manufacturers, Professors, Lecturers and Students from Academia in the study of addiction, psychiatry and mental health.

Conference Highlights

  • Drug Addiction
  • Bipolar Disorders
  • Depression and Anxiety
  • Clinical Interventions
  • Dual Diagnosis
  • Dual diagnosis treatment
  • Drug addiction Pathophysiology
  • Addiction therapy
  • Addictive Disorders
  • Science of Drug abuse
  • Addiction Medicine
  • Dual Diagnosis & Neuroimmune Function
  • Dual Diagnosis & Self-medication
  • Dual Diagnosis & Drug Legalization
  • Dual Diagnosis Rehabilitation & Recovery
  • Epidemiology of Dual disorders

Special Issues

  •  All accepted abstracts will be published in respective OMICS International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.